There’s a somber overtone in the market today on the last day before 9/11 weekend. Those in the US sit and remember the day everything changed. Despite this sentiment there have been several key stocks that have begun catching attention on Friday morning. Some sparked by news, others by shear market momentum. In any case, there’s no doubt that small and micro cap stocks are gaining speed and getting back to business during the first week, back to school. Stocks hitting scanners this morning include: Triangle Petroleum Corporation (NYSEMKT:TPLM), Auris Medical Holding AG (NASDAQ:EARS), Cellectar Biosciences Inc (NASDAQ:CLRB), & Progressive Care Inc (OTCMKTS:RXMD).
Triangle Petroleum Corporation (NYSEMKT:TPLM) has been a big runner today. The company recently announced that it has been acquired by White Deer Energy. What does this mean for TPLM? RockPile will move forward with a debt-free balance sheet and adequate capital to fund growth. RockPile’s Management Team will also remain intact. Also, RockPile and White Deer are mutually committed to growing RockPile ‘the right way’…according to the company, they will focus on never sacrificing service quality to achieve scale. Shares of TPLM have managed to climb more than 60% in early morning trading and with well above average trading volume for the day.
Auris Medical Holding AG (NASDAQ:EARS) announced today that it has reached the midpoint for enrollment in the HEALOS Phase 3 clinical trial of AM-111 in idiopathic sudden sensorineural hearing loss. Patients are randomized to receive AM-111 0.4 mg/mL, 0.8 mg/mL or placebo in a 1:1:1 ratio; oral corticosteroids are given as reserve therapy in case of insufficient hearing recovery by Day 7. The primary efficacy endpoint for the trial is the improvement of pure tone hearing thresholds from baseline to Day 28. Shares are up significantly on Friday having pull up more than 15% since Thursday’s close.
Cellectar Biosciences Inc (NASDAQ:CLRB) announced earlier this week that Jim Caruso, CEO of Cellectar, will present at the 18th Annual Rodman & Renshaw Global Investment Conference being held at the Lotte New York Palace Hotel from September 11-13, 2016. Cellectar Biosciences is developing phospholipid drug conjugates (PDCs) designed to provide cancer targeted delivery of diverse oncologic payloads to a broad range of cancers and cancer stem cells. Since Tuesday, shares of CLRB have increased by as much as 60% and on increased trading volume compared to the last 2 months.
Progressive Care Inc (OTCMKTS:RXMD) announced yesterday that it has formed a new wholly owned subsidiary: Smart Medical Alliance Inc., a healthcare management services organization. The company believes that the need for outsourced support for providers is increasing and estimates the market in the state of Florida to be over $1 billion annually. For the week, the market for RXMD has seen an increase in trading volume and price movement between $0.027-$0.03. Over the last 3 months, shares prices have seen highs of $0.0539.